Sanofi logs six trial updates: new Nuvaxovid, frexalimab, colitis studies and Fabry data lockNov 13Weekly roundup, 10 itemsfexofenadinefrexalimabUpdated
FDA grants accelerated approval to belantamab mafodotin-blmf for multiple myelomaNov 6Regulatory decisionbelantamabbelantamab mafodotin
Regeneron registers Phase 1b hemodialysis study, Phase 1 Graves' disease trialOct 9Weekly roundup, 6 itemsamrecibartbortezomib
FDA approves subcutaneous Sarclisa Escena with on-body injector for multiple myelomaJul 15Regulatory decisionisatuximabisatuximab-irfc
FDA approves Sarclisa Escena, a new dosage form from SanofiJul 9Regulatory decisionisatuximabisatuximab-irfc